Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Sigurs, R. Bjarnason, F. Sigurbergsson, B. Kjellman (2000)
Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.American journal of respiratory and critical care medicine, 161 5
H. Juntti, J. Kokkonen, T. Dunder, M. Renko, A. Niinimäki, M. Uhari (2003)
Association of an early respiratory syncytial virus infection and atopic allergyAllergy, 58
V. Noble, M. Murray, M. Webb, J. Alexander, A. Swarbrick, A. Milner (1997)
Respiratory status and allergy nine to 10 years after acute bronchiolitisArchives of Disease in Childhood, 76
Susan Prescott, Barbara King, T. Strong, Patrick Holt (2003)
The value of perinatal immune responses in predicting allergic disease at 6 years of ageAllergy, 58
C. Pullan, E. Hey (1982)
Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy.British Medical Journal (Clinical research ed.), 284
O. Meurman, O. Ruuskanen, H. Sarkkinen, P. Hänninen, P. Halonen (1984)
Immunoglobulin class‐specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassayJournal of Medical Virology, 14
Glezen Wp, L. Taber, A. Frank, Kasel Ja (1986)
Risk of primary infection and reinfection with respiratory syncytial virus.American journal of diseases of children, 140 6
K. McConnochie, K. Roghmann (1989)
Wheezing at 8 and 13 years: Changing importance of bronchiolitis and passive smokingPediatric Pulmonology, 6
M. Waris, P. Halonen, T. Ziegler, S. Nikkari, G. Obert (1988)
Time-resolved fluoroimmunoassay compared with virus isolation for rapid detection of respiratory syncytial virus in nasopharyngeal aspiratesJournal of Clinical Microbiology, 26
R. Liard, B. Leynaert, M. Zureik, Béguin Fx, F. Neukirch (2000)
Using Global Initiative for Asthma guidelines to assess asthma severity in populations.The European respiratory journal, 16 4
U. Schauer, S. Hoffjan, J. Bittscheidt, A. Köchling, S. Hemmis, S. Bongartz, V. Stephan (2002)
RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of lifeEuropean Respiratory Journal, 20
J. Blanco, J. Richardson, M. Darnell, A. Rowzee, L. Pletneva, D. Porter, G. Prince (2002)
Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats.The Journal of infectious diseases, 185 12
M. Waris (1991)
Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B.The Journal of infectious diseases, 163 3
S. Prescott, C. Macaubas, T. Smallacombe, B. Holt, P. Sly, P. Holt (1999)
Development of allergen-specific T-cell memory in atopic and normal childrenThe Lancet, 353
M. Murray, M. Webb, C. O’Callaghan, A. Swarbrick, A. Milner (1992)
Respiratory status and allergy after bronchiolitis.Archives of Disease in Childhood, 67
R. Stein, D. Sherrill, W. Morgan, C. Holberg, M. Halonen, L. Taussig, A. Wright, F. Martinez (1999)
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 yearsThe Lancet, 354
E. Jong, P. Vieira, P. Kalinski, J. Schuitemaker, Yuetsu Tanaka, E. Wierenga, M. Yazdanbakhsh, M. Kapsenberg (2002)
Microbial Compounds Selectively Induce Th1 Cell-Promoting or Th2 Cell-Promoting Dendritic Cells In Vitro with Diverse Th Cell-Polarizing Signals1The Journal of Immunology, 168
M. Eriksson, R. Bennet, M. Rotzén‐Östlund, M. Sydow, B. Wirgart (2002)
Population‐based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care settingActa Pædiatrica, 91
N. Sigurs, R. Bjarnason, F. Sigurbergsson, B. Kjellman, B. Björkstén (1995)
Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.Pediatrics, 95 4
N. Sigurs, P. Gustafsson, R. Bjarnason, F. Lundberg, S. Schmidt, F. Sigurbergsson, B. Kjellman (2005)
Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.American journal of respiratory and critical care medicine, 171 2
A. Kotaniemi-Syrjänen, T. Reijonen, K. Korhonen, M. Korppi (2002)
Wheezing requiring hospitalization in early childhood: Predictive factors for asthma in a six‐year follow‐upPediatric Allergy and Immunology, 13
J. Mertsola, T. Ziegler, O. Ruuskanen, T. Vanto, A. Koivikko, P. Halonen (1991)
Recurrent wheezy bronchitis and viral respiratory infections.Archives of Disease in Childhood, 66
S. Turner, S. Young, L. Landau, P. Souëf (2002)
Reduced lung function both before bronchiolitis and at 11 yearsArchives of Disease in Childhood, 87
P. McNamara, B. Flanagan, Lisa Baldwin, P. Newland, C. Hart, R. Smyth (2004)
Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitisThe Lancet, 363
C. Thornton, J. Upham, Matthew Wikström, B. Holt, G. White, M. Sharp, P. Sly, P. Holt (2004)
Functional Maturation of CD4+CD25+CTLA4+CD45RA+ T Regulatory Cells in Human Neonatal T Cell Responses to Environmental Antigens/Allergens1The Journal of Immunology, 173
R. Dodge, Fernando Martinez, M. Cline, Michael Lebowitz, Benjamin Burrows (1996)
Early childhood respiratory symptoms and the subsequent diagnosis of asthma.The Journal of allergy and clinical immunology, 98 1
It has been suggested that a respiratory syncytial virus (RSV) infection in infancy increases the likelihood of development of asthma in childhood. The RSV epidemics have a special 2‐yr pattern in Finland and this allows the evaluation of the association of RSV and asthma by epidemiological means. We evaluated whether being 0–6 months of age during an RSV epidemic has an impact on the use of asthma medication later in the childhood. The consumption of asthma medication at the age of 3–16 yr and the number of those entitled to special reimbursement for asthma medication were identified for a total of 637,922 children. These subjects were grouped in cohorts according to whether they had been aged 0–6 months (exposed) or not (unexposed) during an RSV epidemic. The means of the proportions taking asthma medication and of those receiving reimbursement were calculated for each cohort. The means of the proportions in the unexposed vs. exposed cohorts were 20.5% vs. 20.3% for consumption and 4.8% vs. 4.9% for reimbursement. These differences were insignificant. In conclusion exposure to a RSV epidemic in infancy does not increase the consumption of asthma medicines at the population level.
Pediatric Allergy and Immunology – Wiley
Published: Mar 1, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.